CYP2C19 Genotype Predictor of Gastric Acid Suppression
NCT01824199
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
funding
Conditions
Esophagitis
Interventions
DRUG:
Omeprazole
Sponsor
Mayo Clinic